|
United Therapeutics Corp Common
(UTHR)
|
12.9 |
$825M |
|
2.7M |
308.27 |
|
Ascendis Pharma Sponsored ADR
(ASND)
|
12.7 |
$813M |
|
5.2M |
155.86 |
|
Argenx Se Sponsored ADR
(ARGX)
|
11.4 |
$731M |
|
1.2M |
591.87 |
|
Madrigal Pharmaceuticals Common
(MDGL)
|
10.5 |
$670M |
|
2.0M |
331.23 |
|
Krystal Biotech Common
(KRYS)
|
7.7 |
$492M |
|
2.7M |
180.30 |
|
Blueprint Medicines Corp Common
(BPMC)
|
5.3 |
$341M |
|
3.9M |
88.51 |
|
Apellis Pharmaceuticals Common
(APLS)
|
4.2 |
$267M |
|
12M |
21.87 |
|
Avidity Biosciences Common
(RNA)
|
3.5 |
$225M |
|
7.6M |
29.52 |
|
Xenon Pharmaceuticals Common
(XENE)
|
3.0 |
$193M |
|
5.7M |
33.55 |
|
Soleno Therapeutics Common
(SLNO)
|
2.8 |
$180M |
|
2.5M |
71.45 |
|
Kymera Therapeutics Common
(KYMR)
|
2.8 |
$177M |
|
6.5M |
27.37 |
|
Sarepta Therapeutics Common
(SRPT)
|
2.7 |
$171M |
|
2.7M |
63.82 |
|
Amicus Therapeutics Common
(FOLD)
|
2.6 |
$167M |
|
21M |
8.16 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
2.2 |
$142M |
|
11M |
12.74 |
|
Vera Therapeutics Common
(VERA)
|
2.1 |
$137M |
|
5.7M |
24.02 |
|
Merus N V Common
(MRUS)
|
2.0 |
$126M |
|
3.0M |
42.09 |
|
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
1.7 |
$108M |
|
2.8M |
39.07 |
|
Intra-cellular Therapies Common
(ITCI)
|
1.3 |
$83M |
|
625k |
131.92 |
|
Alkermes Common
(ALKS)
|
1.3 |
$81M |
|
2.5M |
33.02 |
|
Biocryst Pharmaceuticals Common
(BCRX)
|
1.0 |
$65M |
|
8.7M |
7.50 |
|
Ocular Therapeutix Common
(OCUL)
|
0.9 |
$59M |
|
8.1M |
7.33 |
|
Centessa Pharmaceuticals Sponsored Adr
(CNTA)
|
0.9 |
$58M |
|
4.1M |
14.38 |
|
89bio Common
(ETNB)
|
0.7 |
$46M |
|
6.4M |
7.27 |
|
Mannkind Corp Common
(MNKD)
|
0.7 |
$44M |
|
8.8M |
5.03 |
|
Vaxcyte Common
(PCVX)
|
0.6 |
$38M |
|
1.0M |
37.76 |
|
Tourmaline Bio Common
(TRML)
|
0.6 |
$37M |
|
2.4M |
15.21 |
|
Ultragenyx Pharmaceutical Common
(RARE)
|
0.5 |
$30M |
|
830k |
36.21 |
|
Taysha Gene Therapies Common
(TSHA)
|
0.4 |
$28M |
|
20M |
1.39 |
|
Uniqure Nv Common
(QURE)
|
0.4 |
$23M |
|
2.2M |
10.60 |
|
Monte Rosa Therapeutics Common
(GLUE)
|
0.3 |
$22M |
|
4.6M |
4.64 |
|
Autolus Therapeutics Sponsored ADR
(AUTL)
|
0.2 |
$15M |
|
9.9M |
1.55 |
|
Septerna Common
(SEPN)
|
0.1 |
$7.7M |
|
1.3M |
5.79 |
|
Whitehawk Therapeutics Common
(WHWK)
|
0.1 |
$5.1M |
|
2.8M |
1.78 |